CompanyBuilt for the validation,
Built for the validation,
not the hypothesis
Who we are, who's building it, and what we've shipped so far.
Mission
Most drugs don't fail because the science was wrong.
They fail because nobody can tell which patients they will work on.
Hypothesis is no longer the bottleneck. It's the validation that follows.
GAIA-BT closes that loop, from patient readout, AI optimization, validation, and back again. K-GEM connects the ecosystem that produces the evidence; GAIA-Phil is the intelligence that reasons over it.
Our Core Values
& Principles
Research
Responsibility
Integrity for Life
Passion for Science
Affection for People
Respect
People
The people building it
Leadership
Functional leads
Advisory board · 6
Timeline
How we got here
- 2026· JUNE
First Paid PoC - Cyron Therapeutics
- 2026· MAY
GBSA-selected Gyeonggi AI Membership Company
- 2026· MAY
Selected for Gyeonggi Level-up Program
- 2026· APRIL
MOU with Jeju Technopark for AI-driven Jeju BIO
- 2026· MARCH
GAIA-Agents Live Now
- 2026· MARCH
Verified AI Voucher Supplier
- 2025· October
Keynote Speaker at BioJapan
- 2025· September
MOU with YUHAN CARE for GAIA-Elix Joint R&D
- 2025· August
Joint R&D Agreement with Cedars-Sinai for GAIA-Onco
- 2025· August
Selected for Seoul AI Hub's High-Performance Computing Infrastructure Program
- 2025· JUNE
BIO International Convention Partnering
- 2025· APRIL
Selected for NIBR Tech Transfer Scale-Up
- 2025· FEBRUARY
RISE Project Agreement with Hallym University
- 2024· DECEMBER
Certified Venture Enterprise
- 2024· NOVEMBER
Completed Seed Funding
- 2024· OCTOBER
Established R&D Center
- 2024· JUNE
Certified Woman-owned, Small & Mid-sized Startup
See Certifications below
- 2024· APRIL
Selected for FATES Acceleration
- 2024· March 21
Established
